IDiyas

For the Inventor, By the Inventor

Los Altos, CA, United States of America

Diane E Nedberge

USPTO Granted Patents = 17

Average Co-Inventor Count = 3.2

ph-index = 14

Forward Citations = 1,083(Granted Patents)


Company Filing History:

goldMedal17 out of 1,062 
 
Alza Corporation
 patents

Years Active: 1986-2001

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6248348 - Incorporating poly-N-vinly amide in a transdermal system (2001-06-19),
2. 6174545 - Drug delivery devices and process of manufacture (2001-01-16),
3. 6007837 - Drug delivery devices and process of manufacture (1999-12-28),
4. 5919478 - Incorporating poly-N-vinyl amide in a transdermal system (1999-07-06),
5. 5641504 - Skin permeation enhancer compositions using glycerol monolinoleate (1997-06-24),
6. 5512292 - Transdermal contraceptive formulations methods and devices (1996-04-30),
7. 5500222 - Transdermal administration of oxybutynin (1996-03-19),
8. 5411740 - Transdermal administration of oxybutynin (1995-05-02),
9. 5376377 - Transdermal contraceptive formulations, methods and devices (1994-12-27),
10. 5320850 - Transdermal delivery of the gestogen ST-1435 and devices therefor (1994-06-14),
11. 5314694 - Transdermal formulations, methods and devices (1994-05-24),
12. 5198223 - Transdermal formulations, methods and devices (1993-03-30),
13. 5122382 - Transdermal contraceptive formulations, methods and devices (1992-06-16),
14. 4816258 - Transdermal contraceptive formulations (1989-03-28),
15. 4788062 - Transdermal administration of progesterone, estradiol esters, and (1988-11-29),

Title: Diane E Nedberge: Innovating Transdermal Drug Delivery Systems

Introduction:

In the world of pharmaceuticals, the quest for efficient drug delivery has been ongoing. Diane E Nedberge, a seasoned inventor and researcher based in Los Altos, CA, has made significant contributions to this field. With a remarkable portfolio of 17 patents, Diane is an expert in refining transdermal drug delivery systems. Let us explore some of his latest patents, career highlights, and notable collaborations.

Latest Patents:

Among Diane's recent breakthroughs is the patent for incorporating poly-N-vinyl amide into a transdermal system. This composition involves a matrix that enables continuous administration of a drug in a therapeutically effective amount. The addition of poly-N-vinyl amide not only enhances drug permeation through the skin but also improves system stability and adhesion.

Another noteworthy patent explores an improved process for manufacturing transdermal drug delivery devices. This method eliminates the need to preload the body-contacting layer with a drug, revolutionizing the production of devices with drug reservoirs exceeding saturation levels. This innovation has significant implications for the pharmaceutical industry, offering simplified and more efficient manufacturing processes.

Career Highlights:

Diane E Nedberge has dedicated his career to Alza Corporation, a renowned company in the field of drug delivery systems. Alza Corporation, known for its cutting-edge pharmaceutical technologies, has provided a nurturing environment for Diane's inventive spirit to flourish. With 17 patents to his credit, Diane's contributions have undoubtedly played a vital role in advancing drug delivery methods.

Collaborations:

Innovation often thrives through collaboration, and Diane has been fortunate to work alongside accomplished peers. Among his collaborators are Robert M Gale and Linda E Atkinson. Their combined expertise has resulted in groundbreaking innovations in transdermal drug delivery systems. Collaborations like these highlight the importance of interdisciplinary teamwork in advancing scientific research and development.

Conclusion:

Diane E Nedberge's remarkable journey in the field of transdermal drug delivery technology has led to significant advancements and improved patient care. His expertise and inventive mindset have paved the way for groundbreaking innovations, making drug delivery more efficient, reliable, and patient-friendly. We eagerly anticipate future breakthroughs from Diane and his dedicated team at Alza Corporation, as they continue to shape the future of pharmaceutical advances.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…